Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-14
2006-11-14
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S247000
Reexamination Certificate
active
07135489
ABSTRACT:
A stable crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide is described. This crystal structure, designated Form B, is more stable, has favorable handling properties and is characterized by its melting point, x-ray and other physical characterizations.
REFERENCES:
patent: 5633272 (1997-05-01), Talley et al.
patent: 5643933 (1997-07-01), Talley et al.
patent: 6441014 (2002-08-01), Talley et al.
patent: 2005/0143432 (2005-06-01), Parthasaradhi et al.
patent: 2005/0272787 (2005-12-01), Sajja et al.
patent: WO 95/00501 (1995-01-01), None
patent: WO 96/38442 (1996-12-01), None
Rouhi, Chemical and Engineering News, Feb. 24, 2003, pp. 32-35.
Gaud Henry T
McLaughlin Kathleen T
Medich John R
Talley John J
Yonan Edward E
Boss Brandon S.
Fitzsimmons Patricia K.
G. D. Searle & Co.
Powers Fiona T.
LandOfFree
Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3638269